Skip to main content

Biofourmis

Biofourmis develops a technology platform that utilizes remote patient monitoring and AI-driven analytics to facilitate in-home healthcare, enabling patients to receive inpatient-level care at home. This approach addresses hospital capacity issues and reduces readmission rates by providing continuous care and timely interventions for chronic conditions.

Needham, United States · HQ
Founded 201531330K+ followers
  • Artificial Intelligence
  • Data & Analytics
  • Digital Health
  • Healthcare Technology
  • Software Only
Updated 5 months ago

Funding

Raised to date

$455MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

across 4 rounds

CHGAMOV+2

$20M · Series D Extension

Announced Jul 2022

Disclosed cumulative: $455M

4/4

Founders

3 founders

Kuldeep Singh

Founder & CEO

Rachna Garg

Co-Founder & COO

Saurabh Bhatnagar

Co-Founder & CTO

Product

Problem

Traditional healthcare models often struggle with hospital capacity, staffing shortages, medication management, and effectively managing patients with chronic conditions, leading to increased costs and suboptimal patient outcomes. Furthermore, patient engagement in traditional care management is often limited, hindering the effectiveness of treatment plans.

Solution

Biofourmis offers a technology platform that leverages remote patient monitoring and AI-driven analytics to enable in-home healthcare and optimize various aspects of the healthcare continuum, from drug development to care delivery. The platform facilitates inpatient-level care at home for appropriate patients, freeing up hospital beds for those requiring more intensive care. By scaling care delivery and maximizing staff efficiency, Biofourmis addresses staffing shortages and reduces the burden on healthcare professionals. The platform also provides disease-specific care pathways and personalized medication management, leading to improved patient outcomes and reduced readmission rates.

Target Audience

Biofourmis primarily serves health systems, pharmaceutical companies, and payers seeking to expand access to care, optimize medication management, improve patient outcomes, and reduce healthcare costs.

Features

  • Remote patient monitoring through wearable biosensors and other connected devices.
  • AI-powered analytics for early detection of patient deterioration and proactive intervention.
  • Digital clinical trial solutions for remote enrollment and improved participant access.
  • Precision digital recruitment tools to identify and enroll appropriate trial participants.
  • Dose optimization guided by individual patient data and a network of specialty clinicians.
  • Real-world evidence generation through active and passive data collection for enhanced patient insights.
  • 70+ disease-specific care pathways for proactive care and intervention.
  • Digital tools for virtual and in-person care coordination to drive better patient engagement.
This profile is AI-generated and may contain inaccuracies.